ArticleHepatology communications2026
THBS1+ macrophages fuel pathogenic inflammation in alcohol-associated liver disease.
Article in Hepatology communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlcohol-associated liver disease (ALD) is one of the most common chronic liver diseases worldwide, with a pathological spectrum ranging from simple steatosis to steatohepatitis and, ultimately, cirrhosis. Severe alcohol-associated hepatitis (sAH) arises acutely within this continuum as a rapidly developing inflammatory condition associated with high mortality and poor prognosis.
methodsTo investigate important cellular subpopulations, we integrated single-cell RNA sequencing (scRNA-seq) data from the peripheral blood and liver tissues of healthy individuals and patients with ALD (including those with alcoholic cirrhosis and sAH). A murine metabolic dysfunction-associated steatotic liver disease and alcohol-associated liver disease (MetALD)-like model was established by combining a metabolic dysfunction-associated steatohepatitis-inducing diet with controlled ethanol exposure. The model was used for histopathological analyses, and CD45+ cells from peripheral blood and liver tissues were isolated for scRNA-seq. Analyses included cell composition profiling, differential expression, pathway enrichment, pseudotime trajectory inference, transcriptional regulatory network reconstruction, and cell-cell communication analysis. In parallel, we generated THBS1‑KO and IL15‑KO immortalized bone marrow-derived macrophages cell lines in vitro and conducted functional assays to validate their roles.
resultsScRNA-seq data revealed significant enrichment of IL15+ monocytes and THBS1+ monocyte-derived macrophages (moMFs) in patients with sAH, both exhibiting highly proinflammatory characteristics. Pseudotime analysis indicated that circulating IL15+ monocytes could dynamically differentiate into hepatic THBS1+ moMFs. Pathological staining and scRNA-seq data from the MetALD mouse model yielded similar results, further confirming the dynamic evolution of IL15+ monocytes into THBS1+ moMFs. In vitro cellular experiments also substantiated the proinflammatory roles of THBS1 and IL15.
conclusionsOur study reveals that circulating IL15+ monocytes dynamically differentiate into hepatic THBS1+ moMFs, and the combined proinflammatory action of these subsets accelerates the progression of ALD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.